Trials / Completed
CompletedNCT01526252
Reference Population for Speckle Tracking Imaging
Establishing a Reference Population for Normal Left Ventricular Function Parameters to Validate the Use of Two Dimensional Speckle Tracking Imaging Software in the Scar Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 91 (actual)
- Sponsor
- Ottawa Heart Institute Research Corporation · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The SCAR study uses a software program entitled QLAB, a proprietory program, developed by Philips Healthcare (Philips Healthcare, Andover, MA). Literature on two-dimensional speckle tracking imaging (2DSTE) is growing, but data relevant to the population in the SCAR study is minimal. Accumulation of data relevant for a population of subjects will provide a set of normal values for interpretation of 2DSTE and minimize any influences from differences in data produced from different companies. This data may also assist other researchers investigate other cardiac diseases and abnormalities.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2012-07-01
- Completion
- 2015-01-01
- First posted
- 2012-02-03
- Last updated
- 2017-04-24
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01526252. Inclusion in this directory is not an endorsement.